[The association between Helicobacter pylori virulence factor genotypes and gastroduodenal diseases in children]

J J Ying1, X L Shu1, G Long1

  • 1Gastrointestinal Laboratory, Children's Hospital, Zhejiang University School of Medicine,National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou 310052, China.

Insights

Common Helicobacter pylori virulence factors like cagA and vacA do not correlate with the severity of gastric disease in children. These gene combinations do not predict clinical outcomes in pediatric H. pylori infections.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Pediatric Infectious Diseases

Context:

  • Pediatric gastroduodenal diseases are often associated with Helicobacter pylori (Hp) infection.
  • Understanding the role of Hp virulence factors in disease pathogenesis is crucial for effective treatment and prevention strategies.

Purpose:

  • To investigate the association between specific Helicobacter pylori virulence factor genotypes and the pathological changes in gastric mucosa of children.
  • To determine if these genotypes correlate with the degree and activity of inflammation in pediatric gastroduodenal diseases.

Summary:

  • This study analyzed 68 pediatric Hp strains for virulence factors including cagA, vacA, oipA, babA, and dupA.
  • No statistically significant association was found between these virulence factor genotypes or their combinations and the presence of superficial gastritis, peptic ulcer, or the degree and activity of gastric inflammation.
  • The findings indicate that common Hp virulence genes do not predict clinical outcomes in children.

Impact:

  • This research clarifies that common Hp virulence factors do not influence the clinical presentation or severity of gastroduodenal diseases in children.
  • The results suggest that diagnostic and therapeutic strategies for pediatric H. pylori infections should not rely on the detection of these specific virulence genotypes.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
637
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
197
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
155
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
464
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
371
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
449